Pediatric Drug Product Development through to Commercialization
In recent years, there has been a notable shift away from the traditional route of administration for pediatric medicines, namely oral liquid formulations, to solid oral dose formulations such as granules and minitablets.
Meeting the requirements of the EU Pediatric Regulation (EC1901/2006 and EC1902/2006) and the US requirement for inclusion of Pediatric Investigation Plans (PIP) in all new Marketing Authorisations, Almac’s US headquartered client sought to develop a pediatric dosage form of their existing commercialized adult drug product.
This case study explores the successful partnership of Almac, our US client partner and third party vendor, Merz in delivering a minitablet in stickpack sachet pediatric formulation for a first in class product with a robust manufacturing process suitable for routine commercial manufacture.
View ResourceCommercial Services
Almac Pharma Services provide a wide range of customized commercial services from supporting product launch, manufacturing and / or packaging drug product, to securing supply chain with global serialization solutions.
Our flexible, quality-led commercial solutions range from orphan drug launches to ongoing high-volume commercial product manufacture, packaging and supply.